Search for 'an,phr: 123' with limit(s): 'au:Carreira Delgado, Patricia Esmeralda'

Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2016 . 34 Suppl 100(5):92-99. , Formato Vancouver: Jewett LR, Kwakkenbos L, Carrier ME, Malcarne VL, Bartlett SJ, Furst DE et al; the SPIN Investigators. Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):92-99.

Place Hold on Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.

Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies.

By Carreira Delgado, Patricia Esmeralda. Arthritis & rheumatology (Hoboken, N.J.), 2016 . 68(9):2338-44. , Formato Vancouver: López Isac E, Martín JE, Assassi S, Simeón CP, Carreira P, Ortego Centeno N et al; Spanish Scleroderma Group. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies. Arthritis Rheumatol. 2016 Sep;68(9):2338-44.

Place Hold on Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies.

An easy prediction rule for diffuse cutaneous systemic sclerosis using only the timing and type of first symptoms and auto-antibodies: derivation and validation.

By Carreira Delgado, Patricia Esmeralda. Rheumatology (Oxford, England), 2016 . 55(11):2023-32. , Formato Vancouver: Van den Hombergh WM, Carreira PE, Knaapen Hans HK, van den Hoogen FH, Fransen J, Vonk MC. An easy prediction rule for diffuse cutaneous systemic sclerosis using only the timing and type of first symptoms and auto-antibodies: derivation and validation. Rheumatology (Oxford). 2016 Nov;55(11):2023-2032.

Place Hold on An easy prediction rule for diffuse cutaneous systemic sclerosis using only the timing and type of first symptoms and auto-antibodies: derivation and validation.

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.

By Carreira Delgado, Patricia Esmeralda. Annals of rheumatic diseases, 2016 . 75(1):163-9. , Formato Vancouver: Elhai M, Avouac J, Walker UA, Matucci Cerinic M, Riemekasten G, Airò P et al; EUSTAR co-authors. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. 2016 Jan;75(1):163-9.

Place Hold on A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.

By Carreira Delgado, Patricia Esmeralda. Rheumatology (Oxford, England), 2015 . 54(7):1262-9. , Formato Vancouver: Hachulla E, Clerson P, Airò P, Cuomo G, Allanore Y, Caramaschi P et al; EUSTAR co-workers. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population. Rheumatology (Oxford). 2015 Jul;54(7):1262-9.

Place Hold on Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.

Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.

By Carreira Delgado, Patricia Esmeralda. Arthritis research & therapy, 2015 . 17(1):63. , Formato Vancouver: Montes A, Pérez Pampín E, Navarro Sarabia F, Moreira V, de la Serna AR, Magallares B et al; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS). Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study. Arthritis Res Ther. 2015 Mar 18;17(1):63.

Place Hold on Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.

Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.

By Carreira Delgado, Patricia Esmeralda. BioMed research international, 2015 . 2015:318364. , Formato Vancouver: García Bermúdez M, López Mejías R, Genre F, Castañeda S, Corrales A, Llorca J et al. Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Biomed Res Int. 2015;2015:318364.

Place Hold on Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.

Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.

By Carreira Delgado, Patricia Esmeralda. Annals of rheumatic diseases, 2016 . 75(7):1285-92. , Formato Vancouver: Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E, Distler O et al; EUSTAR coauthors. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Ann Rheum Dis. 2016 Jul;75(7):1285-92.

Place Hold on Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.

FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors.

By Joven Ibáñez, Beatriz Esther | Carreira Delgado, Patricia Esmeralda. Pharmacogenomics, 2015 . 16(4):333-45. , Formato Vancouver: Montes A, Pérez Pampin E, Joven B, Carreira P, Fernández Nebro A, Del Carmen Ordóñez M et al. FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors. Pharmacogenomics. 2015;16(4):333-45.

Place Hold on FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors.

Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review.

By Carreira Delgado, Patricia Esmeralda. Rheumatology international, 2015 . 35(9):1447-59. , Formato Vancouver: García de la Peña Lefebvre P, Nishishinya MB, Pereda CA, Loza E, Sifuentes Giraldo WA, Román Ivorra JA et al. Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review. Rheumatol Int. 2015 Sep;35(9):1447-59.

Place Hold on Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review.

Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.

By Carreira Delgado, Patricia Esmeralda | Riscos Alvárez, Marina de los. Medicine, 2015 . 94(39):e1554. , Formato Vancouver: Ortiz Sanjuán F, Blanco R, Riancho Zarrabeitia L, Castañeda S, Olivé A, Riveros A et al. Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review. Medicine (Baltimore). 2015 Sep;94(39):e1554.

Place Hold on Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.

Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.

By Galindo Izquierdo, María | Carreira Delgado, Patricia Esmeralda. Medicine, 2015 . 94(1):e267. , Formato Vancouver: Rúa Figueroa Í, Richi P, López Longo FJ, Galindo M, Calvo Alén J, Olivé Marqués A et al; EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology). Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences. Medicine (Baltimore). 2015 Jan;94(1):e267.

Place Hold on Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.

Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2015 . 33(4 Suppl 91):S31-5. , Formato Vancouver: Ochoa E, Martín JE, Assasi S, Beretta L, Carreira P, Guillén A et al; Spanish Scleroderma Group. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S31-5.

Place Hold on Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.

Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2015 . 33(4 Suppl 91):S75-9. , Formato Vancouver: Sandmeier B, Jäger VK, Nagy G, Carreira PE, Tzankov A, Widuchowska M et al. Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S75-9.

Place Hold on Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database.

An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2015 . 33(4 Suppl 91):S47-54. , Formato Vancouver: Brand M, Hollaender R, Rosenberg D, Scott M, Hunsche E, Tyndall A et al; EUSTAR Co-Investigators. An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S47-54.

Place Hold on An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database.

A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.

By Carreira Delgado, Patricia Esmeralda. Microvascular research, 2015 . 102:19-24. , Formato Vancouver: Ingegnoli F, Boracchi P, Gualtierotti R, Smith V, Cutolo M, Foeldvari I et al. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study. Microvasc Res. 2015 Nov;102:19-24.

Place Hold on A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.

Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.

By Carreira Delgado, Patricia Esmeralda. The Journal of rheumatology, 2014 . 41(1):99-105. , Formato Vancouver: Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA et al. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol. 2014 Jan;41(1):99-105.

Place Hold on Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.

Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.

Place Hold on Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.

Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis.

By Carreira Delgado, Patricia Esmeralda. PloS one, 2014 . 9(9):e106823. , Formato Vancouver: Genre F, López Mejías R, García Bermúdez M, Castañeda S, González Juanatey C, Llorca J et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. PLoS One. 2014 Sep 3;9(9):e106823.

Place Hold on Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis.

Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.

By Carreira Delgado, Patricia Esmeralda. Journal of clinical epidemiology, 2014 . 67(6):706-14. , Formato Vancouver: Johnson SR, Naden RP, Fransen J, Van den Hoogen F, Pope JE, Baron M et al. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. J Clin Epidemiol. 2014 Jun;67(6):706-14.

Place Hold on Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.

Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.

By Carreira Delgado, Patricia Esmeralda. Arthritis research & therapy, 2014 . 16(2):R66. , Formato Vancouver: Márquez A, Ferreiro-Iglesias A, Dávila-Fajardo CL, Montes A, Pascual-Salcedo D, Pérez-Pampin E et al. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis. Arthritis Res Ther. 2014 Mar 11;16(2):R66.

Place Hold on Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.

Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus.

By Carreira Delgado, Patricia Esmeralda. Arthritis research & therapy, 2014 . 16(3):R128. , Formato Vancouver: Alonso-Pérez E, Suárez-Gestal M, Calaza M, Blanco FJ, Suárez A, Santos MJ; European Consortium of SLE DNA Collections. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus. Arthritis Res Ther. 2014 Jun 19;16(3):R128.

Place Hold on Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus.

Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis.

By Carreira Delgado, Patricia Esmeralda. Mediators of inflammation, 2014 . 2014:756279. , Formato Vancover: López-Mejías R, Genre F, García-Bermúdez M, Ubilla B, Castañeda S, Llorca J et al. Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. Mediators Inflamm. 2014;2014:756279.

Place Hold on Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis.

Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis.

By Carreira Delgado, Patricia Esmeralda. Arthritis research & therapy, 2014 . 16(4):R146. , Formato Vancouver: García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, Llorca J, González-Juanatey C et al. Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. Arthritis Res Ther. 2014 Jul 10;16(4):R146.

Place Hold on Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis.

Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. American journal of human genetics, 2014 . 94(1):47-61. , Formato Vancouver: Mayes MD, Bossini-Castillo L, Gorlova O, Martín JE, Zhou X, Chen WV et al. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet. 2014 Jan 2;94(1):47-61.

Place Hold on Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.

Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus.

By Carreira Delgado, Patricia Esmeralda. Arthritis & rheumatology (Hoboken, N.J.), 2014 . 66(12):3521-3. , Formato Vancouver: López-Isac E, Bossini-Castillo L, Guerra SG, Denton C, Fonseca C, Assassi S et al. Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus. Arthritis Rheumatol. 2014 Dec;66(12):3521-3.

Place Hold on Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus.

Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.

By Joven Ibáñez, Beatriz Esther | Carreira Delgado, Patricia Esmeralda. Pharmacogenetics and genomics, 2014 . 24(5):238-45. , Formato Vancouver: Montes A, Pérez-Pampin E, Narváez J, Cañete JD, Navarro-Sarabia F, Moreira V et al. Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis. Pharmacogenet Genomics. 2014 May;24(5):238-45.

Place Hold on Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.

Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study.

Place Hold on Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study.

Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

By Carreira Delgado, Patricia Esmeralda. Clinical and experimental rheumatology, 2013 . 31(2 Suppl 76):96-102. , Formato Vancouver: Heijnen IA, Foocharoen C, Bannert B, Carreira PE, Caporali R, Smith V et al. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study. Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):96-102.

Place Hold on Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci.

By Carreira Delgado, Patricia Esmeralda. Human Molecular Genetics, 2013 . 22(19):4021-9. , Formato Vancouver: Martín JE, Assassi S, Díaz-Gallo LM, Broen JC, Simeón CP, Castellvi I, et al; Spanish Scleroderma Group; SLEGEN consortium; U.S. Scleroderma GWAS group; BIOLUPUS. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet. 2013 Oct 1;22(19):4021-9.

Place Hold on A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci.

Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database.

By Carreira Delgado, Patricia Esmeralda. Rheumatology (Oxford, England), 2013 . 52(3):560-7. , Formato Vancouver: Schneeberger D, Tyndall A, Kay J, Søndergaard KH, Carreira PE, Morgiel E et al. Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database. Rheumatology (Oxford). 2013 Mar;52(3):560-7.

Place Hold on Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database.

The role of the NLRP1 gene in systemic sclerosis: a replication study

By Carreira Delgado, Patricia Esmeralda. Clinical and Experimental Rheumatology, 2013 . 31(2 Suppl 76):187-8. , Formato Vancouver: Teruel M, Simeón CP, Broen J, Carreira P, García de la Peña P, Aguirre MÁ et al. Spanish Scleroderma Group. The role of the NLRP1 gene in systemic sclerosis: a replication study. Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):187-8.

Place Hold on The role of the NLRP1 gene in systemic sclerosis: a replication study

Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis.

By Carreira Delgado, Patricia Esmeralda. Tissue Antigens, 2013 . 82(6):405-9. , Formato Vancouver: García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, González-Juanatey C, Llorca J et al. Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. Tissue Antigens. 2013 Dec;82(6):405-9.

Place Hold on Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis.

Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.

By Carreira Delgado, Patricia Esmeralda. Annals of the rheumatic diseases, 2013 . 72(7):1233-8. , Formato Vancouver: Díaz-Gallo LM, Simeón CP, Broen JC, Ortego-Centeno N, Beretta L, Vonk MCet al. Spanish Scleroderma Group. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility. Ann Rheum Dis. 2013 Jul;72(7):1233-8.

Place Hold on Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.

The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. PloS one, 2013 . 8(1):e54419. , Formato Vancouver: Carmona FD, Martin JE, Beretta L, Simeón CP, Carreira PE, Callejas JL et al. Spanish Scleroderma Group. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PLoS One. 2013;8(1):e54419.

Place Hold on The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.

New insight on the Xq28 association with systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. Annals of the Rheumatic Diseases, 2013 . 72(12):2032-8. , Formato Vancouver: Carmona FD, Cénit MC, Diaz-Gallo LM, Broen JC, Simeón CP, Carreira PE et al. Spanish Scleroderma Group. New insight on the Xq28 association with systemic sclerosis. Ann Rheum Dis. 2013 Dec;72(12):2032-8.

Place Hold on New insight on the Xq28 association with systemic sclerosis.

A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda | Criado Carrasco, Gabriel | Rey Cerros, Manuel José del | Izquierdo Alvárez, Elena | Ortiz Romero, Pablo Luis | Pablos Álvarez, José Luis | Usátegui Corral, Alicia. Annals of the rheumatic diseases, 2013 . 72(12):2018-23. , Formato Vancouver: Usategui A, Criado G, Izquierdo E, Del Rey MJ, Carreira PE, Ortiz P et al. A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis. Ann Rheum Dis. 2013 Dec;72(12):2018-23.

Place Hold on A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

By Carreira Delgado, Patricia Esmeralda. Annals of the Rheumatic Diseases, 2013 . 72(11):1747-55. , Formato Vancouver: Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira ET AL. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013 Nov;72(11):1747-55.

Place Hold on 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.

By Carreira Delgado, Patricia Esmeralda. Arthritis and Rheumatism, 2013 . 65(11):2737-47. , Formato Vancouver: Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013 Nov;65(11):2737-47.

Place Hold on 2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.

Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.

By Carreira Delgado, Patricia Esmeralda. Annals of the rheumatic diseases, 2013 . 72(4):602-7. , Formato Vancouver: Bossini-Castillo L, Martin JE, Broen J, Simeón CP, Beretta L, Gorlova OY et al. Spanish Scleroderma Group. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis. 2013 Apr;72(4):602-7.

Place Hold on Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.

Validation of Potential Classification Criteria for Systemic Sclerosis.

By Carreira Delgado, Patricia Esmeralda. Arthritis and Rheumatism, 2012 . 64(3):358–367. , Formato Vancouver: Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA Jr, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken). 2012 Mar;64(3):358-67.

Place Hold on Validation of Potential Classification Criteria for Systemic Sclerosis.

The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. Genes and Immunity, 2012 . 13(2):191-6. , Formato Vancouver: Martín JE, Carmona FD, Broen JC, Simeón CP, Vonk MC, Carreira P, et al. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis. Genes Immun. 2012 Feb;13(2):191-6.

Place Hold on The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.

Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. Annals of the Rheumatic Diseases, 2012 . 71(1):114-9. , Formato Vancouver: Carmona FD, Gutala R, Simeón CP, Carreira P, Ortego-Centeno N, Vicente-Rabaneda E, et al. Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis. Ann Rheum Dis. 2012 Jan;71(1):114-9.

Place Hold on Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis.

No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. Tissue Antigens, 2012 . 80(3):254-8. , Formato Vancouver: Cénit MC, Simeón CP, Fonollosa V, Espinosa G, Beltrán E, Sáez-Comet L, et al. No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis. Tissue Antigens. 2012 Sep;80(3):254-8.

Place Hold on No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis.

Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.

By Carreira Delgado, Patricia Esmeralda | Galindo Izquierdo, María. Lupus, 2012 . 21(10):1063-76. , Formato Vancouver: Fernández-Nebro A, de la Fuente JL, Carreño L, Izquierdo MG, Tomero E, Rúa-Figueroa I, et al. Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study. Lupus. 2012 Sep;21(10):1063-76.

Place Hold on Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.

KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor.

By Carreira Delgado, Patricia Esmeralda. Arthritis Research & Therapy, 2012 . 14(6):R273. , Formato Vancouver: Bossini-Castillo L, Simeón CP, Beretta L, Broen J, Vonk MC, Callejas JL, et al. KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor. Arthritis Res Ther. 2012 Dec 27;14(6):R273.

Place Hold on KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor.

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.

By Carreira Delgado, Patricia Esmeralda. Arthritis Care & Research, 2012 . 64(3):351-7. , Formato Vancouver: Fransen J, Johnson SR, Van den Hoogen F, Baron M, Allanore Y, Carreira PE, et al. Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken). 2012 Mar;64(3):351-7.

Place Hold on Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.

Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.

By Carreira Delgado, Patricia Esmeralda. Arthritis and Rheumatism, 2012 . 64(5):1653-64. , Formato Vancouver: Lagares D, Busnadiego O, García-Fernández RA, Kapoor M, Liu S, Carter DE, et al. Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. Arthritis Rheum. 2012 May;64(5):1653-64.

Place Hold on Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.

Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis.

By Carreira Delgado, Patricia Esmeralda. Genes and Immunity, 2012 . 13(6):458-60. , Formato Vancouver: McKinney C, Broen JC, Vonk MC, Beretta L, Hesselstrand R, Hunzelmann N, et al. Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. Genes Immun. 2012 Sep;13(6):458-60.

Place Hold on Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis.

Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study.

By Carreira Delgado, Patricia Esmeralda. PloS One, 2012 . 7(9):e45356. , Formato Vancouver: Alonso-Pérez E, Suárez-Gestal M, Calaza M, Ordi-Ros J, Balada E, Bijl M, et al. Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study. PLoS One. 2012;7(9):e45356.

Place Hold on Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study.